Low-dose renin inhibitor and low-dose AT1-receptor blocker therapy ameliorate target-organ damage in rats harbouring human renin and angiotensinogen genes
暂无分享,去创建一个
R. Dechend | E. Shagdarsuren | S. Meiners | A. Fiebeler | D. Muller | P. Gratze | W. Derer | D. Feldman | R. Webb | B. Pilz
[1] M. Wellner,et al. Complement Activation in Angiotensin II–Induced Organ Damage , 2005, Circulation research.
[2] M. Wellner,et al. Aliskiren, a Human Renin Inhibitor, Ameliorates Cardiac and Renal Damage in Double-Transgenic Rats , 2005, Hypertension.
[3] Karen A. Griffin,et al. Pathophysiology of Hypertensive Renal Damage: Implications for Therapy , 2004, Hypertension.
[4] A. Nishiyama,et al. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin. , 2004, The Journal of clinical investigation.
[5] M. Zenke,et al. Immunosuppressive treatment protects against angiotensin II-induced renal damage. , 2002, The American journal of pathology.
[6] G. Nguyen,et al. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. , 2002, The Journal of clinical investigation.
[7] D. Ganten,et al. Blood pressure-independent effects in rats with human renin and angiotensinogen genes. , 2000, Hypertension.
[8] V. Dzau,et al. The renin-angiotensin-aldosterone system: a specific target for hypertension management. , 1999, American journal of hypertension.
[9] D. Ganten,et al. Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.